Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy is a once-weekly subcutaneous injection, so it goes under the skin rather than into your digestive system — which means food in your stomach at the time of the jab does not affect how well the medicine is absorbed. You can take your weekly Wegovy dose with or without food, and the day's meals don't need to change around it. That said, the timing of your meals after an injection, and the pattern of eating you build alongside treatment, do matter for managing side effects and getting the most from the medicine. This is a question our prescribers hear most weeks, so it's worth answering properly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
No. This is the core answer, and it often surprises people. Oral medicines (tablets and capsules) can be significantly affected by food because digestion changes how quickly and completely the active ingredient crosses from the gut into the bloodstream. Wegovy works differently. It is injected into the fatty tissue just beneath the skin (abdomen, thigh, or upper arm), and it is absorbed directly from there into the circulation, bypassing the gut entirely.
Because the stomach plays no role in that process, having eaten a large meal, a light snack, or nothing at all before your injection makes no meaningful difference to the amount of semaglutide your body receives. The semaglutide overview on our site explains the mechanism in more detail, but the practical implication is straightforward: there is no required fasting window before or after your weekly dose.
This is confirmed by the NHS semaglutide information page, which does not list any food-timing restriction for the injection. The medicine's summary of product characteristics similarly places no meal-timing requirement on the weekly injection. Inject when it is convenient and consistent for you.
Part of the confusion comes from oral semaglutide, specifically the Wegovy tablet, which does carry strict food-timing rules. Oral semaglutide must be taken on an empty stomach, first thing in the morning, with a small amount of plain water, and you must wait at least 30 minutes before eating, drinking anything other than water, or taking other oral medicines. That is because the absorption-enhancing technology in the tablet is highly sensitive to food.
The weekly injection shares an active ingredient with the tablet but is an entirely different formulation and delivery method. If you have been reading about whether to take Wegovy on an empty stomach and found conflicting answers, the likely cause is that advice intended for the tablet has been applied to the injection. They are not interchangeable instructions.
There is also a second source of confusion: Wegovy strongly reduces appetite, so many people find they are simply not hungry around the time of their weekly dose. That is the medicine working, not a requirement.
Yes, though not through absorption. The most commonly reported side effects of Wegovy are gastrointestinal (nausea, vomiting, diarrhoea, constipation, and reflux) and these are most noticeable in the first few days after starting or after a dose increase. What and how you eat around that time can make a real difference to how you feel, even though it does not change the drug level in your blood.
Practical steps that many people find helpful: eating smaller portions more slowly, choosing lower-fat and less intensely flavoured meals for the day or two after an injection, drinking plenty of water, and sitting upright after eating rather than lying down. Avoiding alcohol around injection day is also sensible. These are lifestyle adjustments, not medical requirements, and your prescriber can advise on approaches tailored to your situation.
If you are curious about how eating habits fit alongside treatment more broadly, the weight-loss treatment overview covers the lifestyle component clearly. The side-effect pattern typically settles as your body adjusts, and most people find it manageable within the first few weeks at each dose level. If nausea is severe or persistent, that is a conversation for your prescriber, not something to push through alone.
Completely different rules apply. The oral Wegovy tablet (approved by the MHRA in June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management) must be taken on an empty stomach every morning. The 30-minute fasting window before food or drink (other than a small amount of plain water) is not optional; skipping it meaningfully reduces how much semaglutide reaches the bloodstream.
If you are considering the tablet rather than the injection, or are thinking about switching, the distinction matters. Many patients ask whether it is better to take Wegovy on an empty stomach, and the answer varies considerably depending on which formulation you are using. A page exploring whether it is best to take Wegovy on an empty stomach covers the tablet-specific guidance in detail. The Wegovy pillar page outlines both formulations side by side.
Choosing between injection and tablet is a clinical conversation. The right format depends on your lifestyle, preferences, and medical history, exactly the kind of question the prescribers at our clinical team work through with patients regularly. If you have questions ahead of a consultation, including whether you should take Wegovy on an empty stomach given your chosen formulation, our FAQs cover many of the common ones, and our team is reachable via the contact page seven days a week.
When you are ready to explore whether Wegovy is clinically suitable for you, start your free consultation and a GPhC-registered prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.